This pilot study will assess the safety and feasibility of intravenous (IV) ketamine in older
adults with Treatment-Resistant Depression (TRD). In addition, this study will develop and
utilize innovative methodological approaches to demonstrate the feasibility of precision
medicine and mobile health approaches in depression treatment.